221 related articles for article (PubMed ID: 12236910)
1. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer].
García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM
Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910
[TBL] [Abstract][Full Text] [Related]
2. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
3. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
[TBL] [Abstract][Full Text] [Related]
5. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
[TBL] [Abstract][Full Text] [Related]
7. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
[TBL] [Abstract][Full Text] [Related]
9. Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
Ochoa-Figueroa MA; Uña-Gorospe J; Allende-Riera A; Cárdenas-Negro JC; Muñoz-Iglesias J; Cabello-García D; De Sequera-Rahola M; Martínez-Gimeno E
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):249-56. PubMed ID: 23067526
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
[TBL] [Abstract][Full Text] [Related]
11. [Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer].
Oliva JP; Pimentel G; Borrón M; Peralta R; Ortiz R; Oliver B; Díaz N; Sánchez I; Vázquez AM; Baum RP
Rev Esp Med Nucl; 2001 Jun; 20(4):282-8. PubMed ID: 11940415
[TBL] [Abstract][Full Text] [Related]
12. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods].
Behr TM; Goldenberg DM; Scheele JR; Wolf FG; Becker W
Dtsch Med Wochenschr; 1997 Apr; 122(15):463-70. PubMed ID: 9147937
[TBL] [Abstract][Full Text] [Related]
13. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.
Hughes K; Pinsky CM; Petrelli NJ; Moffat FL; Patt YZ; Hammershaimb L; Goldenberg DM
Ann Surg; 1997 Nov; 226(5):621-31. PubMed ID: 9389396
[TBL] [Abstract][Full Text] [Related]
14. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].
Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP
Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study.
Rodriguez-Bigas MA; Bakshi S; Stomper P; Blumenson LE; Petrelli NJ
Arch Surg; 1992 Nov; 127(11):1321-4. PubMed ID: 1444794
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
[TBL] [Abstract][Full Text] [Related]
17. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
18. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
[TBL] [Abstract][Full Text] [Related]
19. Anticarcinoembryonic antigen immunoscintigraphy with a 99mTc-Fab' fragment (Immu 4) in primary and recurrent colorectal cancer. A prospective study.
Lechner P; Lind P; Binter G; Cesnik H
Dis Colon Rectum; 1993 Oct; 36(10):930-5. PubMed ID: 8404384
[TBL] [Abstract][Full Text] [Related]
20. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
